← Back to Search

Device

Group 1--Short Dwell for Infections

N/A

Waitlist Available

Led By Leslie Parker

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 hours

Awards & highlights

Study Summary

This trial will study whether a shorter time for feeding through a tube will reduce contamination of the tube.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Amount of Contamination

Secondary outcome measures

Adverse Event Rate

Gastrointestinal Inflammation - Bio Rad

Gastrointestinal Inflammation - Calprotectin

+1 more

Trial Design

2Treatment groups

Active Control

Group I: Group 1--Short DwellActive Control1 Intervention

Premature VLBW (very low birth weight) male and female infants will be randomly assigned to have their feeding tubes removed at 0-48 hours for the first 4 weeks of life.The feeding tube lumen, interluminal liquid and hub will be analyzed for level of contamination.

Group II: Group 2--Long DwellActive Control1 Intervention

Premature VLBW (very low birth weight) male and female infants will be randomly assigned to have their feeding tubes removed at 7 days for the first 4 weeks of life.The feeding tube lumen, interluminal liquid and hub will be analyzed for level of contamination.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Pediatric Dermatology Res AllianceUNKNOWN

National Eczema AssociationUNKNOWN

1 Previous Clinical Trials

58 Total Patients Enrolled

National Center for Advancing Translational Science (NCATS)NIH

99 Previous Clinical Trials

36,158 Total Patients Enrolled

1 Trials studying Infections

11 Patients Enrolled for Infections

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to enroll in this medical study?

"This clinical trial is seeking 302 neonates aged between 30 and 40 weeks who have contracted an infection. To be eligible to participate, they must have been born to a mother above 18 years of age with English or Spanish as their first language, weighed less than 1500 grams at birthtime and had the feeding tube inserted within 24 hours of delivery; additionally, it is expected that participants will require postnatal nutrition for 4 weeks after birth and the mother should not test positive for COVID-19."

Answered by AI

How many subjects are engaged in this research?

"Absolutely. The clinicaltrial.gov page shows that this study, which was first posted on May 10th 2017, is actively in need of individuals to participate. An estimated 302 patients are required for the trial at one site."

Answered by AI

Are individuals aged 80 years or younger capable of participating in this research?

"This study is specifically tailored to those aged 30 Weeks to 40 Weeks. In addition, there are 13 studies for minors and 33 for seniors."

Answered by AI

Is participation in this research project available to the public currently?

"This medical research is actively recruiting, as evidenced by clinicaltrials.gov; first posted on May 10th 2017 and last amended on March 23rd 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination

2017. "Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03728608.